Watching small kidney tumors over time instead of treating
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study follows people with small, solid kidney tumors using active surveillance (regular monitoring) rather than immediate surgery or treatment. It may help you understand whether careful watching is a safe option for certain early kidney tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can read and understand the consent form, or you have support to do so
- You must agree in writing to join the active surveillance monitoring plan
- You are over 50 years old
- You have a single (one-sided) small solid kidney mass under 2 cm
- Your kidney tumor is not causing symptoms
- No prior kidney cancer (renal neoplasia) and no spreading cancer to other organs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to treat a specific type of kidney cyst: surgery or active surveillance (regular scans and check-ins). It aims to see which approach works better for people with Bosniak 3 cysts.
This study is a registry that collects information on how people with localized kidney tumors are treated (either active treatment or watchful waiting). It may help doctors better understand which approaches work best for different patients.
This study tests whether closely monitoring small kidney tumors (less than 4 cm) with regular imaging is a safe and effective option for people who cannot or choose not to have immediate treatment. It involves a biopsy at the start to confirm the tumor type.
This study follows people with kidney cancer who are scheduled for surgery to remove their tumor. It aims to learn more about the disease and how it behaves over time.
This registry follows people who have a small kidney mass found by chance on recent scans. It helps doctors understand the best timing for monitoring and possible treatment, to improve safety and outcomes.
This trial compares two approaches for people with slow-growing, metastatic clear cell kidney cancer: taking a daily pill (belzutifan) or monitoring the cancer closely without treatment. The goal is to see if starting treatment early can help control the cancer longer than waiting.
Hear when a new Kidney Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.